In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few EllieMD Dihexa DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like Nine Anticipated FDA Approvals for January 2026 Guideline Central 2024 FDA approvals exceed average number but have lower sales projections